ArticleInternational journal of pharmaceutics: X2025

Topical transdermal administration of lenalidomide nanosuspensions-based hydrogels against melanoma: In vitro and in vivo studies.

Mengdi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.